Increased regional myocardial perfusion after intracoronary papaverine in patients after coronary artery bypass grafting

Steven Goldman, R. Henry, Mark J Friedman, T. Ovitt, A. Rosenfeld, N. Salomon, J. Copeland

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The objective of coronary artery bypass grafting (CABG) is to increase blood flow to ischemic areas of the myocardium. To determine if this was achieved, anterior wall myocardial perfusion was measured at rest and during intracoronary papaverine (5 mg), with the use of xenon-133 washout in 35 patients. Twelve control patients had no significant diameter narrowing (0% to 25%) of the left anterior descending coronary artery (LAD), 13 patients had >50% narrowing of the LAD, and 10 patents had >50% narrowing of the LAD with patients saphenous vein bypass grafts to the LAD. There was no significant difference in age, LVEDP, and global ejection fraction among the patients. There was no significant difference in anterior wall myocardial perfusion at rest between control subjects (61.0 ± 3.7 ml/min/100 gm) and non-CABG LAD patients (60.2 ± 5.4 ml/min/100 gm), or CABG LAD patients (63.4 ± 4.8 ml/min/100 gm). After coronary arteriolar vasodilatation with papaverine, anterior wall perfusion increased in the CABG patients to 140.6 ± 6.8 ml/min/100 gm. This was significantly greater (p < 0.001) than the increase in the non-CABG LAD patients (72.8 ± 8.1 ml/min/100 gm) but not different from the increase in the control subjects (145.3 ± 8.4 ml/min/100 gm). In three cases, the same patients were studied before and after CABG with identical results. These date indicate that in patients with coronary disease, increases in myocardial perfusion are limited by the resistance of the proximal stenosis independent of vasodilatation distal to the stenosis. After successful CABG, the patent vein graft restores control of myocardial perfusion to the arteriolar bed.

Original languageEnglish (US)
Pages (from-to)563-568
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume83
Issue number4
StatePublished - 1982
Externally publishedYes

Fingerprint

Papaverine
Coronary Artery Bypass
Perfusion
Vasodilation
Pathologic Constriction
Arteries
Transplants
Xenon
Patents
Saphenous Vein
Coronary Disease
Veins
Coronary Vessels
Myocardium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Increased regional myocardial perfusion after intracoronary papaverine in patients after coronary artery bypass grafting. / Goldman, Steven; Henry, R.; Friedman, Mark J; Ovitt, T.; Rosenfeld, A.; Salomon, N.; Copeland, J.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 83, No. 4, 1982, p. 563-568.

Research output: Contribution to journalArticle

@article{c63ff168a09e425ead44455015c662f3,
title = "Increased regional myocardial perfusion after intracoronary papaverine in patients after coronary artery bypass grafting",
abstract = "The objective of coronary artery bypass grafting (CABG) is to increase blood flow to ischemic areas of the myocardium. To determine if this was achieved, anterior wall myocardial perfusion was measured at rest and during intracoronary papaverine (5 mg), with the use of xenon-133 washout in 35 patients. Twelve control patients had no significant diameter narrowing (0{\%} to 25{\%}) of the left anterior descending coronary artery (LAD), 13 patients had >50{\%} narrowing of the LAD, and 10 patents had >50{\%} narrowing of the LAD with patients saphenous vein bypass grafts to the LAD. There was no significant difference in age, LVEDP, and global ejection fraction among the patients. There was no significant difference in anterior wall myocardial perfusion at rest between control subjects (61.0 ± 3.7 ml/min/100 gm) and non-CABG LAD patients (60.2 ± 5.4 ml/min/100 gm), or CABG LAD patients (63.4 ± 4.8 ml/min/100 gm). After coronary arteriolar vasodilatation with papaverine, anterior wall perfusion increased in the CABG patients to 140.6 ± 6.8 ml/min/100 gm. This was significantly greater (p < 0.001) than the increase in the non-CABG LAD patients (72.8 ± 8.1 ml/min/100 gm) but not different from the increase in the control subjects (145.3 ± 8.4 ml/min/100 gm). In three cases, the same patients were studied before and after CABG with identical results. These date indicate that in patients with coronary disease, increases in myocardial perfusion are limited by the resistance of the proximal stenosis independent of vasodilatation distal to the stenosis. After successful CABG, the patent vein graft restores control of myocardial perfusion to the arteriolar bed.",
author = "Steven Goldman and R. Henry and Friedman, {Mark J} and T. Ovitt and A. Rosenfeld and N. Salomon and J. Copeland",
year = "1982",
language = "English (US)",
volume = "83",
pages = "563--568",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Increased regional myocardial perfusion after intracoronary papaverine in patients after coronary artery bypass grafting

AU - Goldman, Steven

AU - Henry, R.

AU - Friedman, Mark J

AU - Ovitt, T.

AU - Rosenfeld, A.

AU - Salomon, N.

AU - Copeland, J.

PY - 1982

Y1 - 1982

N2 - The objective of coronary artery bypass grafting (CABG) is to increase blood flow to ischemic areas of the myocardium. To determine if this was achieved, anterior wall myocardial perfusion was measured at rest and during intracoronary papaverine (5 mg), with the use of xenon-133 washout in 35 patients. Twelve control patients had no significant diameter narrowing (0% to 25%) of the left anterior descending coronary artery (LAD), 13 patients had >50% narrowing of the LAD, and 10 patents had >50% narrowing of the LAD with patients saphenous vein bypass grafts to the LAD. There was no significant difference in age, LVEDP, and global ejection fraction among the patients. There was no significant difference in anterior wall myocardial perfusion at rest between control subjects (61.0 ± 3.7 ml/min/100 gm) and non-CABG LAD patients (60.2 ± 5.4 ml/min/100 gm), or CABG LAD patients (63.4 ± 4.8 ml/min/100 gm). After coronary arteriolar vasodilatation with papaverine, anterior wall perfusion increased in the CABG patients to 140.6 ± 6.8 ml/min/100 gm. This was significantly greater (p < 0.001) than the increase in the non-CABG LAD patients (72.8 ± 8.1 ml/min/100 gm) but not different from the increase in the control subjects (145.3 ± 8.4 ml/min/100 gm). In three cases, the same patients were studied before and after CABG with identical results. These date indicate that in patients with coronary disease, increases in myocardial perfusion are limited by the resistance of the proximal stenosis independent of vasodilatation distal to the stenosis. After successful CABG, the patent vein graft restores control of myocardial perfusion to the arteriolar bed.

AB - The objective of coronary artery bypass grafting (CABG) is to increase blood flow to ischemic areas of the myocardium. To determine if this was achieved, anterior wall myocardial perfusion was measured at rest and during intracoronary papaverine (5 mg), with the use of xenon-133 washout in 35 patients. Twelve control patients had no significant diameter narrowing (0% to 25%) of the left anterior descending coronary artery (LAD), 13 patients had >50% narrowing of the LAD, and 10 patents had >50% narrowing of the LAD with patients saphenous vein bypass grafts to the LAD. There was no significant difference in age, LVEDP, and global ejection fraction among the patients. There was no significant difference in anterior wall myocardial perfusion at rest between control subjects (61.0 ± 3.7 ml/min/100 gm) and non-CABG LAD patients (60.2 ± 5.4 ml/min/100 gm), or CABG LAD patients (63.4 ± 4.8 ml/min/100 gm). After coronary arteriolar vasodilatation with papaverine, anterior wall perfusion increased in the CABG patients to 140.6 ± 6.8 ml/min/100 gm. This was significantly greater (p < 0.001) than the increase in the non-CABG LAD patients (72.8 ± 8.1 ml/min/100 gm) but not different from the increase in the control subjects (145.3 ± 8.4 ml/min/100 gm). In three cases, the same patients were studied before and after CABG with identical results. These date indicate that in patients with coronary disease, increases in myocardial perfusion are limited by the resistance of the proximal stenosis independent of vasodilatation distal to the stenosis. After successful CABG, the patent vein graft restores control of myocardial perfusion to the arteriolar bed.

UR - http://www.scopus.com/inward/record.url?scp=0020079660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020079660&partnerID=8YFLogxK

M3 - Article

C2 - 6977686

AN - SCOPUS:0020079660

VL - 83

SP - 563

EP - 568

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 4

ER -